United Pharm (033270) — Cash Flow Quality Index
United Pharm (033270) has a Cash Flow Quality Index of 2.11x as of December 2025. Operating cash flow of ₩23.01 Billion exceeds net income of ₩10.93 Billion, indicating high earnings quality where cash backs reported profits. Explore 033270 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
United Pharm Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for United Pharm across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check United Pharm (033270) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for United Pharm (2011–2025)
Year-by-year earnings quality comparison for United Pharm. For live market cap and the full company financial profile, see United Pharm stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | ₩51.14 Billion | ₩38.31 Billion | ▲ +61.7% |
| 2024 | 0.83x | ₩26.79 Billion | ₩32.45 Billion | ▼ -19.9% |
| 2023 | 1.03x | ₩49.77 Billion | ₩48.26 Billion | ▼ -26.8% |
| 2022 | 1.41x | ₩63.78 Billion | ₩45.28 Billion | ▼ -8.5% |
| 2021 | 1.54x | ₩44.09 Billion | ₩28.65 Billion | ▲ +10.8% |
| 2020 | 1.39x | ₩36.96 Billion | ₩26.61 Billion | ▲ +12.5% |
| 2019 | 1.23x | ₩38.15 Billion | ₩30.92 Billion | ▲ +6.0% |
| 2018 | 1.16x | ₩36.86 Billion | ₩31.67 Billion | ▲ +17.1% |
| 2017 | 0.99x | ₩27.68 Billion | ₩27.86 Billion | ▼ -35.4% |
| 2016 | 1.54x | ₩30.02 Billion | ₩19.51 Billion | ▲ +32.6% |
| 2014 | 1.16x | ₩21.31 Billion | ₩18.37 Billion | ▼ -25.3% |
| 2013 | 1.55x | ₩18.97 Billion | ₩12.21 Billion | ▲ +16.3% |
| 2012 | 1.34x | ₩21.88 Billion | ₩16.38 Billion | ▼ -2.3% |
| 2011 | 1.37x | ₩27.62 Billion | ₩20.21 Billion | — |